A genetic study of steroid-resistant nephrotic syndrome: Relationship between polymorphism -173 G to C in the MIF gene and serum level MIF in children

Journal of Developmental Origins of Health and Disease

Volumn 7, Issue 1, 2016, Pages 102-107

  Ramayani, O R ^a   Sekarwana, N ^b   Trihono, P P ^c   Sadewa, A H ^d   Lelo, A ^a  

^a UNIVERSITY OF SUMATERA UTARA   (Indonesia)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF INDONESIA   (Indonesia)

^d GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

macrophage inhibitory factor; nephrotic syndrome; steroid resistant

Indexed keywords

ISOMERASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF PROTEIN, HUMAN;

ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHILD; FEMALE; GENETICS; HUMAN; MALE; NEPHROTIC SYNDROME; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; NEPHROTIC SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84946781653     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174415007850     Document Type: Article

References (18)

1. Berdeli A, Mir S, Ozkayin N, et al. Association of macrophage migration inhibitory factor-173 C allele polymorphism with steroid resistance in children with nephrotic syndrome. Pediatr Nephrol. 2005; 20, 1566-1571.
2. Vivarelli M, D'Urbano LE, Stringini G, Ghiggeri GM, Caridi G. Association of macrophage migration inhibitory factor-173C allele with childhood nephrotic syndrome. Pediatr Nephrol. 2008; 23, 743-748.
3. ISKDC. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr. 1981; 98, 561-564.
4. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976; 58, 259-263.
5. Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification and stratification. Pediatrics. 2003; 111, 1416-1421.
6. R&D Systems, USA. Quantikine ELISA. Human MIF Immunoassay. Catalogue number DMF008 lot 294789. R&D Systems, Inc. Minneapolis, United States of America.
7. Yende C, Angus DC, Kong L, et al. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J. 2009; 23, 2403-2411.
8. Renner P, Roger T, Bochud PY. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J. 2012; 26, 907-916.
9. Shastry BS. SNPs in disease gene mapping, medicinal drug development and evolution. J Hum Genet. 2007; 52, 871-880.
10. Che R, Zhang A. Mechanism of glucocorticoid resistance in idiopathic nephrotic syndrome. Kidney Blood Press Res. 2013; 37, 360-378.
11. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant. 2003; 18, 26-29.
12. Donnely SC, Bucala R. Macrophage pigration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflamatory disease. Mol Med. 1997; 502-507.
13. Petrovsky N, Socha L, Silva D, et al. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter regulator. Immunol Cell Biol. 2003; 81, 137-143.
14. Lan HY. Role of macrophage migration inhibition factor in kidney disease. Nephron Exp Nephrol. 2008; 109, e79-e83.
15. Van Rossum EF, Lamberts SW. Glucocorticoid resistance syndrome a diagnostic and therapeutic approach. Best Pract Res Clin Endocrinol Metab. 2006; 20, 611-626.
16. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003; 3, 1038-1048.
17. Rice EK, Tesch GH, Cao Z, et al. Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int. 2003; 63, 1265-1275.
18. Murea M, Register TC, Divers J, et al. Relationship between serum MCP-1 and subclinical kidney disease. BMC Nephrol. 2012; 13, 148-164.